CARL

Handel nachbörslich: 13.85 0.07 +0.51%

Carlsmed Inc (CARL)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Carlsmed Inc Stock (CARL) Company Profile

Carlsmed Inc

Healthcare (1161)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CARL's Discussions on Twitter

Vergleichen Sie CARL mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CARL Carlsmed Inc	13.78	346.30M	0	0	0	0.00
VEEV Veeva Systems Inc	279.18	45.01B	2.86B	780.66M	1.20B	4.72
TEM Tempus Ai Inc	69.63	11.53B	803.32M	-709.10M	-212.68M	-7.8003
DOCS Doximity Inc	64.02	11.58B	550.17M	201.35M	232.07M	1.00
HQY Healthequity Inc	89.27	8.04B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	35.35	6.01B	906.14M	-52.62M	89.62M	-0.3621

Carlsmed Inc Aktie (CARL) Neueste Nachrichten

Finanzdaten der Carlsmed Inc-Aktie (CARL)

Es liegen keine Finanzdaten für Carlsmed Inc (CARL) vor. Überprüfen Sie andere Aktien für weitere Informationen.

Carlsmed Inc (CARL)

Carlsmed Inc Stock (CARL) Company Profile

Vergleichen Sie CARL mit anderen Aktien

Carlsmed Inc Aktie (CARL) Neueste Nachrichten

Big Boost for Personalized Cervical Fusion: Add-On Code - Orthopedics This Week

Heartflow raises $317M, pops 66% at market open - BioWorld MedTech

Carlsmed’s $100.5M IPO fuels 3D printed spinal implants growth - 3D Printing Industry

Carlsmed’s aprevo implants receive CMS NTAP for cervical fusion procedures - TipRanks

Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - Ortho Spine News

Carlsmed's Aprevo Implants Receive CMS NTAP Approval For Cervical Fusion Procedures Under FY2026 IPPS Final Rule - 富途牛牛

Carlsmed's Aprevo Personalized Interbody Implants Receive CMS NTAP for Cervical Fusion Procedures - AInvest

AI medtech firm Carlsmed prices $100.5M IPO - MSN

US Life Sciences IPOs Revive with Medtech Companies Leading the Way - AInvest

Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - Bloomberg.com

Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery - MarketScreener

Carlsmed announces completion of first aprevo cervical procedure - TipRanks

Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery - Ortho Spine News

Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery. - AInvest

Carlsmed’s Nasdaq Debut Gets $100.5M - San Diego Business Journal

Carlsmed Launches $100.5 Million Initial Public Offering - Global Legal Chronicle

Carlsbad-based medical technology company begins trading on Nasdaq - MSN

Latham & Watkins Advises on Carlsmed, Inc.’s US$100.5 Million Initial Public Offering - Latham & Watkins LLP

Carlsmed Insider Bought Shares Worth $899,985, According to a Recent SEC Filing - MarketScreener

Carlsmed director Mittendorff buys $20 million in shares By Investing.com - Investing.com UK

Carlsmed director Philip Young buys $900k in shares By Investing.com - Investing.com Canada

Carlsmed (CARL) director Sidow buys $199,995 in shares By Investing.com - Investing.com India

Carlsmed (CARL) director Sidow buys $199,995 in shares - Investing.com Australia

Carlsmed director Philip Young buys $900k in shares - Investing.com

Carlsmed director Mittendorff buys $20 million in shares - Investing.com

Carlsmed, Inc. Completes Initial Public Offering - TipRanks

Carlsmed 6.7M share IPO priced at $15 per share - MSN

Carlsmed: Redefining Precision And Personalization In Spine Surgery With AI-Powered Aprevo - RTTNews

Carlsmed, Inc.(NasdaqGS: CARL) added to NASDAQ Composite Index - MarketScreener

Carlsmed: Spine Play Does Not Have My Backing Yet (NASDAQ:CARL) - Seeking Alpha

Carlsmed times IPO with reimbursement boon - Axios

Carlsmed Inc. (CARL): MedTech Makes Uninspiring Debut, Opens Flat and Trades Below Issue - Smartkarma

AI Spine Surgery Firm Carlsmed Shares Fall 3.3% After IPO - Bloomberg

Carlsmed begins trading on Nasdaq at $15 per share - Investing.com

Carlsmed (CARL): Assessing the Post-IPO Dip in a High-Growth MedTech Disruptor - AInvest

Carlsmed begins trading on Nasdaq at $15 per share By Investing.com - Investing.com Canada

Carlsmed, Inc Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Carlsmed, Inc Rings the Opening Bell - Nasdaq

Carlsmed Prices $100.5 Million IPO - MarketScreener

Finanzdaten der Carlsmed Inc-Aktie (CARL)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie CARL